Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.37 |
| ▸ | IDH1 | O75874 | 12/20 | 0.36 |
| ▸ | IDH2 | P48735 | 1/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.32 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.32 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | BCL6 | P41182 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6181367 | 0.83 | PRMT6 (0.38) | PRMT6IDH1IDH2MAPTNPC1 | |
| SCHEMBL5547613 | 0.81 | KDM4E (0.31) | — | |
| SCHEMBL7873623 | 0.80 | ALDH1A1 (0.44) | MAPTSLC6A2SLC6A4SLC6A3 | |
| SCHEMBL6182022 | 0.77 | PRMT6 (0.37) | PRMT6IDH1IDH2MAPTNPC1 | |
| SCHEMBL7877675 | 0.76 | GABRA1 (0.37) | PRMT6IDH1IDH2GABRA1GABRG2 | |
| SCHEMBL6178955 | 0.75 | PRMT6 (0.34) | PRMT6IDH1IDH2SCN9A | |
| SCHEMBL6176672 | 0.72 | L3MBTL1 (0.37) | PRMT6IDH1IDH2GABRA1GABRG2 | |
| SCHEMBL5215254 | 0.71 | CYP1A2 (0.41) | MAPTNPC1 | |
| SCHEMBL5211817 | 0.71 | NPSR1 (0.38) | MAPTNPC1 | |
| SCHEMBL6176976 | 0.71 | PRMT6 (0.34) | PRMT6IDH1IDH2SCN9AMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040198758-A1 | N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040198758-A1 | N-heterocyclyl substituted thienyloxy-pyrimidines used as herbicides | CBR3, CBR1, CBX8 | PRMT6 2296/4885IDH1 214/4885IDH2 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.